Dysregulation of BMP6 signaling was linked to the pathogenesis of PCOS, contributing to ovulatory dysfunction [42,43] and associated metabolic disturbances, which can elevate cardiovascular risk in affected women. Here, BMP6 is linked to polycystic ovary syndrome.